✦ LIBER ✦

Effects of clofibrate on glucose tolerance, serum insulin, serum lipoproteins and plasma fibrinogen

✍ Scribed by H. Lithell; J. Boberg; H. Hedstrand; K. Hellsing; S. Ljunghall; B. Vessby

Publisher: Springer
Year: 1977
Tongue: English
Weight: 622 KB
Volume: 12
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00561405

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effects of clofibrate on plasma gluc

The effects of clofibrate on plasma glucose, lipoproteins, fibrinogen, and other biochemical and haematological variables in patients with mature onset diabetes mellitus

✍ G. D. Calvert; L. Blight; J. Franklin; J. Oliver; P. Wise; A. S. Gallus 📂 Article 📅 1980 🏛 Springer 🌐 English ⚖ 757 KB

The effect of dimethylbiguanide on gluco

The effect of dimethylbiguanide on glucose tolerance, serum insulin and growth hormone in obese patients

✍ H. Schatz; S. Doci; R. Höfer 📂 Article 📅 1972 🏛 Springer 🌐 English ⚖ 640 KB

Effects of oral administration of maltit

Effects of oral administration of maltitol on plasma glucose, plasma sorbitol, and serum insulin levels in man

✍ Secchi, A. ;Pontiroli, A. E. ;Cammelli, L. ;Bizzi, A. ;Cini, M. ;Pozza, G. 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 545 KB

Short-term and long-term effects of Norp

Short-term and long-term effects of NorplantR-2 on plasma lipoproteins and glucose tolerance

✍ Y. Bala; G. I. Dhall; S. Majumdar 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 405 KB

Effects of atorvastatin on serum lipids,

Effects of atorvastatin on serum lipids, lipoproteins, and hemostasis

✍ Fumihiko Kushiya; Hideo Wada; Kinue Ooi; Yuko Sakurai; Akane Sakaguchi; Maki Nod 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Effect of chronic treatment with enalapr

Effect of chronic treatment with enalapril on glucose tolerance and serum insulin in non-insulin-resistant Japanese patients with essential hypertension

✍ T. Baba; T. Kodama; T. Ishizaki 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 534 KB

The effect of enalapril, an angiotensin converting enzyme inhibitor, on glucose tolerance and serum insulin response to a glucose load has been evaluated in 8 non-obese patients (3 women and 5 men) with untreated essential hypertension (WHO Stage I or II) and without insulin resistance. Following a